×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 2: Bridge from Evaluation to Access through Collaboration with Payers
Session Chair(s)
Virginia Acha, PhD, MSc
AVP, Global Regulatory Policy
Merck Sharp & Dohme LLC, United Kingdom
Session 2: Bridge from Evaluation to Access through Collaboration with Payers
Speaker(s)
Ansgar Hebborn, PhD, MBA
F. Hoffmann-La Roche AG, Switzerland
Head - Access Policy Affairs Europe
Work Towards Addressing the Evidence Gap
Michael Berntgen, PhD
European Medicines Agency, Netherlands
Head of Scientific Evidence Generation
Payer’s Perspective
Evert Jan van Lente, MS
AOK Bundesverband (Federal Insurer), Germany
Director EU-Affairs
Have an account?